Clinical Trial

Optimal PEEP for Postoperative Oxygenation and Lung Aeration (ULTRASVENT-2)

Study acronym: ULTRASVENT-2
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this multicenter, randomized controlled trial (ULTRASVENT-2) is to evaluate the effect of different positive end-expiratory pressure (PEEP) levels on postoperative oxygenation and lung aeration in adult patients undergoing elective non-cardiac and non-thoracic surgery under general anesthesia. Moving away from traditional binary outcomes, this study utilizes a continuous functional metric, the non-invasive oxygenation index SpO2/FiO2 (S/F ratio), as the primary endpoint to precisely capture the degree of respiratory function preservation. Patients will be stratified into four distinct surgical cohorts based on the type and aggressiveness of the procedure: non-abdominal surgery, major open abdominal surgery, major laparoscopic abdominal surgery, and low-trauma laparoscopic surgery. This adaptive design aims to investigate how protective PEEP strategies interact with varying degrees of surgical trauma and intraoperative pneumoperitoneum, allowing the optimization of mechanical ventilation parameters for routine clinical practice.
Trial Details
NCT Number NCT07613177
Lead Sponsor Moscow Multidisciplinary Clinical Center "Kommunarka"
Conditions Postoperative Complications, Respiratory Insufficiency, Pulmonary Atelectasis, Positive-End Expiratory Pressure, Hypoxemia
Enrollment 360 participants
Start Date 2026-07-01
Primary Completion 2026-12-01 (estimated)
Study Completion 2026-12-20 (estimated)
Updated on ClinicalTrials.gov 2026-05-29